Regulatory Updates, Annex 1 & Sterile Manufacturing Training & Top Tips for Compliant Patient Information Leaflets (PILs)
We’ve had a busy start to 2026, delivering a wide range of GMP and GDP training to organisations across the industry. This newsletter edition highlights key regulatory updates from the UK and EU, along with insights from our recent Annex 1 Gap Assessment and sterile manufacturing training programme in India.
We also share our latest “Top Tips” article on maintaining compliant Patient Information Leaflets (PILs), introduce new EPiC consultant Ralph Harris, and provide details of upcoming events including the RQA IMP Management Essentials webinar and the Making Pharmaceuticals 2026 conference, where EPiC will be exhibiting and presenting.
In this edition, you’ll find:
- Regulatory Updates – UK
- Regulatory Updates – EU
- Onsite Annex 1 Gap Assessment & Sterile Manufacturing Training in India
- EPiC Top Tips: Compliant Patient Information Leaflets (PILs)
- Welcome to the Team – Ralph Harris
- Upcoming RQA Webinar: IMP Management Essentials
- Making Pharmaceuticals 2026 – Conference Sessions & Exhibition
This issue includes updates on important regulatory developments, insights from our recent consultancy projects, practical compliance guidance, and details of where you can meet the EPiC team over the coming months.
WHAT DO YOU REQUIRE?
WE SPECIALISE in helping pharmaceutical and biotechnology companies, as well as other associated healthcare clients, to achieve and maintain regulatory compliance and excellent pharmaceutical quality systems, to best industry standards.
If you need our help and support then please don’t hesitate to contact us.
Call: +44 (0)1244 980544
Email: enquiries@epic-auditors.com